Capacity building in anthelmintic drug discovery

Area of Science:

• Global Health
• Drug Discovery
• Parasitology

Background:

• International collaboration in anthelmintic drug discovery presents unique challenges and opportunities.
• Developing country-based screening centers can significantly contribute to global health initiatives.
• Strengthening infrastructure is crucial for effective neglected tropical disease research.

Purpose of the Study:

• To discuss key considerations for developing anthelmintic screening centers.
• To highlight the productivity of developing country-based screening centers using examples from the Philippines and Egypt.
• To emphasize the benefits of supporting these centers for capacity building and technology diffusion.

Main Methods:

• The chapter discusses critical issues in anthelmintic screening center development.
• It presents case studies from the Philippines and Egypt to illustrate productivity.
• Focuses on the outcomes of infrastructure development in multinational priority areas.

Main Results:

• Developing country screening centers enhance local capacity for anthelmintic drug discovery.
• These centers enable optimal use of specialized resources for endemic parasitic diseases.
• Infrastructure development facilitates improved product development and technology diffusion.

Conclusions:

• International collaboration in anthelmintic drug discovery is vital for building capacity and strengthening research infrastructure.
• Support for developing country screening centers yields significant public health benefits by addressing endemic diseases.
• These initiatives foster inter-institutional relationships and promote global technology transfer for neglected tropical diseases.